Search

everythinglearnresearchcommunity

for

Search:↓

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Diagnosing hyperandrogenism in women is complex and requires accurate testing methods and consideration of SHBG levels.

Gynecologists should provide comprehensive care for transgender patients, including mental health evaluation, hormone therapy, and surgical options, while monitoring for side effects and ensuring patient safety.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

N-acetylcysteine was more effective and had fewer side effects than metformin for improving insulin resistance in women with PCOS.

The document concludes that proper diagnosis and individualized treatment are crucial for managing androgenization in women effectively.

Depression is more common in infertile women with PCOS than those without.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

The study concluded that androstendione and DHEA are important for diagnosing high male hormone levels in women with excessive hair growth.

Phytoandrogens from plants may help treat low testosterone naturally.

Combining lifestyle changes and medication is most effective for managing PCOS symptoms.

Surgery to lower high testosterone in postmenopausal women with certain ovarian tumors doesn't significantly affect their metabolism.

The document concludes that various cosmetic and drug treatments are available for hirsutism, and some new drugs show promise.

Ovarian steroid cell tumors should be considered in adults with hirsutism and high testosterone, with surgery as the main treatment.

Removing a testicular tumor in a dog reduced its aggressive behavior and skin problems.

The conclusion is that published guidelines are improving transgender medical care, but more research and education in transgender medicine are needed.

Nonclassic congenital adrenal hyperplasia is a genetic disorder causing hormone imbalances, affecting fertility and requiring personalized treatment.

With careful management, people with congenital adrenal hyperplasia can have successful pregnancies and become parents.

A boy with a rare form of early puberty caused by a new gene mutation responded well to treatment aimed at reducing testosterone and preserving adult height.

Doctors used a special blood sampling technique to diagnose a woman's rare ovarian tumor that was producing male hormones.

New male hormonal contraceptives show promise but need more research on long-term effects and funding for larger trials.

Testosterone is crucial for development, growth, and various body functions in mammals.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Certain microRNAs in the fluid around eggs are linked to Polycystic Ovary Syndrome and may help diagnose it.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Testosterone therapy seems safe and effective for transgender men with proper care, but more long-term research is needed.